Drug Pipeline

ONC201 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05476939 Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 Diffuse Intrinsic Pontine Glioma Recruiting
NCT05580562 ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) H3 K27M Recruiting
Phase 1
NCT05542407 ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer Endometrial Cancer Recruiting
Sponsors Running ONC201 Trials
Gustave Roussy, Cancer Campus, Grand Paris (1) UNC Lineberger Comprehensive Cancer Center (1) Jazz Pharmaceuticals (1)
Disease Areas
Glioma (2) Endometrial Cancer (1) Sarcoma (1)
Get alerts when ONC201 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free